Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 12, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • COVID INDIA

Tag: COVID INDIA

  • BiotechToday
  • India

Moderna: Covid-19 Vaccine- Sooner than we think?

bioxone November 1, 2020November 1, 2020 1

Avipsha Datta, Department of Biophysics and Molecular Biology, University of Calcutta Covid-19 Vaccine- the one thing we are very much hoping for right now! Well, here is some news update that might give us a little more hope. The Drugmaker Company Moderna has announced that it is preparing to launch its potential Coronavirus vaccine mRNA-1273.Meanwhile, […]

Read More
  • BiotechToday
  • India

COVID UPDATE: Decrease in daily active cases in India

bioxone October 13, 2020October 13, 2020

Camelia Bhattacharyya, Amity University Kolkata The coronavirus, or the virus which has resulted in the whole world to shutdown, the ecosystem to change and us to depend completely on technology (to manage the economic conditions) and their immunity (since its more or less the survival of the fittest) first started its game in Wuhan, China. […]

Read More
  • BiotechToday
  • World

Monoclonal antibodies against SARS-CoV-2 spike protein

bioxone October 6, 2020October 6, 2020

Prama Ghosh, Amity University Kolkata The alarming hypothesis that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic to be around for several years calls for rapid and successful therapies. Though anti-SARS-CoV-2 spike monoclonal antibodies originated from mice have shown robust performance in various immunoassays including western blotting, ELISA, immunofluorescence, and immunoprecipitation, there is still a […]

Read More
  • BiotechToday
  • India
  • World

Elevation of serum IgA and antiphospholipid-IgA antibodies production in Severe COVID-19

bioxone October 2, 2020October 2, 2020

Anwita Sarkar, Team BioXone Based on what we know so far about the complications of COVID-19, it frequently involves complications that bear similarities to autoimmune disorders. Up to now, there are little reports on possible IgA mediated autoimmune responses. A study was conducted to determine the association of COVID-19 with vigorous total IgA responses. It […]

Read More
  • BiotechToday
  • India
  • World

COVID UPDATE: Russian Vaccine enters Phase III trials: A Sputnik moment or a Russian Roulette?

bioxone September 27, 2020September 27, 2020 1

Team BioXone Covid-19 continues to spread globally like wildfire. The vaccine in development is the only hope for prevention and containment. Every capable country is into investing millions to fast track development of vaccines, telescoping the duration of clinical trials from years to months. Russia launched its home-brewed vaccine – SPUTNIK V, in August, based […]

Read More
  • Biotechnopedia
  • DNA-Tales

Role of Angiotensin receptor blockers towards COVID-19

bioxone September 27, 2020September 27, 2020

Debraj Ghosh, Undergraduate student of Medicinal Institute, People’s Friendship Institute of Russia, Moscow, Russia Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)(1) is the strain of coronavirus causes the respiratory illness responsible for the COVID-19 pandemic. It is a positive ssRNA(4) virus that is contagious to humans and is a successor to SARS-CoV-1 according to the U.S. National Institute of Health. The SARS-CoV-2 virion […]

Read More
  • BiotechToday
  • World

Vitamin D significantly reduces Covid-19 mortality by 50%

bioxone September 27, 2020September 27, 2020

-Anuska Sen, Team bioXone It is a well-known fact to all of us that Vitamin D is indispensable in a healthy life. Not only does it help in maintaining proper bone formation and its structure, but it also aids to prevent skin cancer in people. One of the best, easiest and most reliable natural sources […]

Read More
  • BiotechToday
  • World

COVID-19: Extracorporeal carbon dioxide removal as rescue therapy in severe Covid-19 pneumonitis

bioxone September 26, 2020September 26, 2020 9

  Srilagna Sarkar, Amity University Kolkata Coronavirus disease 2019, was first identified in Wuhan where 27 patients cases reported of pneumonia of some unknown aetiology were linked with an open seafood market. Despite several measures, the virus spread rapidly and by 11 March 2020 WHO declared it as a global pandemic. In the majority of patients […]

Read More
  • India

COVID UPDATE: THE REVOLUTIONARY VACCINE

bioxone September 24, 2020September 24, 2020 1

SAMRAT SARKAR, AMITY UNIVERSITY KOLKATA Where the entire world is trying to find a way out of this pandemic situation, Bharat Biotech with collaborated with Washington University School of Medicine in St. Louis have gone for another massive bang on the pandemic by trying a new novel chimp-adenovirus, a single-dose intranasal vaccine for Covid-19 using […]

Read More
  • India

FELUDA – the rapid test strip method to detect COVID-19

bioxone September 21, 2020September 21, 2020

-Ruchita Karmakar, Amity University Kolkata A research team led by Debojyoti Chakraborty and Souvik Maiti of CSIR and TATA group came up with a new test named FELUDA  to detect COVID-19. It’s a paper test strip that gives a precise result within 30 minutes; Approved for commercial launch by the Drugs Controller General of India. […]

Read More

Posts navigation

1 2

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy